Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Montserrat Tech Update.
Press releases published on June 26, 2025
Plus Therapeutics Provides Business Update on CNSide Diagnostics Subsidiary
GlobeNewswire
·
June 26, 2025
U.S. commercial rollout of novel diagnostic platform to begin second half 2025 Underserved CNS cancer diagnostic U.S. market opportunity estimated to be in excess of $6 billion Management to host a conference call today at 9am ET HOUSTON, June 26, 2025 ( …
IQAI Pakistan Strategy Seminar Concludes Successfully, Deeply Empowering Local Traders
GlobeNewswire
·
June 26, 2025
New York, NY, June 26, 2025 (GLOBE NEWSWIRE) -- The IQAI Pakistan Strategy Seminar recently concluded with great success at the Flatties Hotel in Lahore. As a key component of IQAI’s global community-building initiative, the event attracted enthusiastic …
Invivyd Announces Positive Full Phase 1/2 Clinical Data for VYD2311, a Next Generation COVID-19 Monoclonal Antibody for Potential Use as a Non-Vaccine Preventative and for Treatment of Active Infection
GlobeNewswire
·
June 26, 2025
Attractive safety profile demonstrated across all dosing cohorts and routes of administration (IV, SC, and IM); all reported adverse events (AEs) deemed unrelated or classified as mild to moderate and largely related to injection site and infusion …
BILT awarded $15 Million STRATFI contract to support US Air Force maintainers
GlobeNewswire
·
June 26, 2025
GRAPEVINE, Texas, June 26, 2025 (GLOBE NEWSWIRE) -- BILT Incorporated, creators of 3D Intelligent Instructions®, has been awarded a $15 million Strategic Funding Increase (STRATFI) contract by the United States Air Force. The multi-year initiative will …
GDS Announces Results of Annual General Meeting of Shareholders
GlobeNewswire
·
June 26, 2025
SHANGHAI, China, June 26, 2025 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced that it held its Annual …
Aduro Clean Technologies Welcomes David Weizenbach as Chief Operating Officer
GlobeNewswire
·
June 26, 2025
LONDON, Ontario, June 26, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste …
Lantronix Selected by Tier-1 U.S. Wireless Operator to Digitally Monitor 50,000+ Cell Site Generators
GlobeNewswire
·
June 26, 2025
IRVINE, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader of compute and connectivity IoT solutions enabling Edge AI Intelligence, today announced a multi-year agreement with a Tier-1 U.S. mobile network operator to …
Revive Therapeutics Nears Completion of Key Nerve Agent Countermeasure Study with Canadian Department of National Defence Highlighting Significant Stockpiling Opportunity
GlobeNewswire
·
June 26, 2025
TORONTO, June 26, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases and …
Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations
GlobeNewswire
·
June 26, 2025
NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare …
XORTX Announces USD $925,000 Private Placement
GlobeNewswire
·
June 26, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, June 26, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late …
Medicenna Therapeutics Reports Fiscal Year 2025 Financial Results and Operational Highlights
GlobeNewswire
·
June 26, 2025
Updated cash guidance provides runway into at least mid-2026 MDNA11 Phase 1/2 clinical trial on track for data readouts in second half of the year as a single agent and in combination with KEYTRUDA® at medical conferences and a planned KOL event MDNA11 …
Altimmune Announces Positive Topline Results from the IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH
GlobeNewswire
·
June 26, 2025
First product candidate to demonstrate significant MASH effects and weight loss at 24 weeks Trial met its primary endpoint with statistically significant MASH resolution without worsening of fibrosis in up to 59.1% of participants in an ITT analysis …
CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline
GlobeNewswire
·
June 26, 2025
-New Phase 1 clinical data for CTX310™ continues to demonstrate dose-dependent reductions in triglycerides (TG) and low-density lipoprotein (LDL), with peak reduction of up to 82% in TG and up to 86% in LDL, with a well-tolerated safety profile- -Complete …
Opus Genetics Announces VEGA-3 Phase 3 Trial Met its Primary Endpoint for Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia
GlobeNewswire
·
June 26, 2025
Study met its primary and key secondary endpoints, demonstrating rapid and sustained improvement in near visual acuity Safety profile consistent with previous clinical trials and no treatment-related serious adverse events reported in the study No evidence …
Coin Casino Launches Online Casino Real Money $30,000 Bonus Campaign and Expands the Best Online Casino Game Library with 100+ New Titles for Summer 2025
GlobeNewswire
·
June 26, 2025
NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Coin Casino, a licensed crypto gaming platform, has announced the launch of its Summer 2025 Welcome Campaign, offering new players up to $30,000 in bonuses and 50 free spins. Coinciding with this promotion, Coin …
I-Mab Highlights Positive Givastomig Phase 1b Dose Escalation Data in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers at ESMO GI 2025
GlobeNewswire
·
June 26, 2025
71% objective response rate (ORR) (12/17) per RECIST v1.1, with a favorable safety profile 83% ORR (10/12) in patients across doses selected for ongoing dose expansion study Responses observed in patients with low PD-L1 and/or CLDN18.2 expression Updated …
ProFound Therapeutics Announces Multi-Year Strategic Collaboration with Novartis to Discover and Develop Novel Therapeutics for Cardiovascular Disease
GlobeNewswire
·
June 26, 2025
ProFound to receive $25M in upfront and near-term milestone payments with a potential value from downstream milestones of $750M per target ProFound to leverage its ProFoundry™ Platform to mine the expanded proteome to identify previously unknown proteins …
Squad ouvre 400 nouveaux postes pour affirmer sa position de leader français de la Cybersécurité
GlobeNewswire
·
June 26, 2025
Squad, groupe cyber de référence, annonce une vaste campagne de recrutement en 2025 pour accompagner sa forte croissance et mener à bien son plan stratégique sur les prochaines années. Avec plus de mille experts répartis dans douze agences en France, …
GDS Announces the Launch of an Initial Public Offering for its C-REIT on the Shanghai Stock Exchange
GlobeNewswire
·
June 26, 2025
SHANGHAI, China, June 26, 2025 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced that the China …
RBC iShares Expands iShares Core Offering with Launch of New ETF
GlobeNewswire
·
June 26, 2025
TORONTO, June 26, 2025 (GLOBE NEWSWIRE) -- Today, RBC iShares expands its iShares Core exchange traded fund (ETF) lineup with the launch of the iShares Core S…